vs

Side-by-side financial comparison of Essent Group Ltd. (ESNT) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.

Essent Group Ltd. is the larger business by last-quarter revenue ($312.4M vs $208.9M, roughly 1.5× iRhythm Holdings, Inc.). Essent Group Ltd. runs the higher net margin — 49.6% vs 2.7%, a 46.9% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs -0.8%). Essent Group Ltd. produced more free cash flow last quarter ($848.7M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 2.3%).

Essentra PLC is a supplier of plastic and fibre products. The company operates internationally from headquarters in Kidlington, Oxfordshire. It is listed on the London Stock Exchange.

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

ESNT vs IRTC — Head-to-Head

Bigger by revenue
ESNT
ESNT
1.5× larger
ESNT
$312.4M
$208.9M
IRTC
Growing faster (revenue YoY)
IRTC
IRTC
+28.0% gap
IRTC
27.1%
-0.8%
ESNT
Higher net margin
ESNT
ESNT
46.9% more per $
ESNT
49.6%
2.7%
IRTC
More free cash flow
ESNT
ESNT
$834.2M more FCF
ESNT
$848.7M
$14.5M
IRTC
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
2.3%
ESNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ESNT
ESNT
IRTC
IRTC
Revenue
$312.4M
$208.9M
Net Profit
$155.0M
$5.6M
Gross Margin
70.9%
Operating Margin
59.1%
1.1%
Net Margin
49.6%
2.7%
Revenue YoY
-0.8%
27.1%
Net Profit YoY
-7.7%
518.5%
EPS (diluted)
$1.61
$0.18

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESNT
ESNT
IRTC
IRTC
Q4 25
$312.4M
$208.9M
Q3 25
$311.8M
$192.9M
Q2 25
$319.1M
$186.7M
Q1 25
$317.6M
$158.7M
Q4 24
$315.0M
$164.3M
Q3 24
$316.6M
$147.5M
Q2 24
$312.9M
$148.0M
Q1 24
$298.4M
$131.9M
Net Profit
ESNT
ESNT
IRTC
IRTC
Q4 25
$155.0M
$5.6M
Q3 25
$164.2M
$-5.2M
Q2 25
$195.3M
$-14.2M
Q1 25
$175.4M
$-30.7M
Q4 24
$167.9M
$-1.3M
Q3 24
$176.2M
$-46.2M
Q2 24
$203.6M
$-20.1M
Q1 24
$181.7M
$-45.7M
Gross Margin
ESNT
ESNT
IRTC
IRTC
Q4 25
70.9%
Q3 25
71.1%
Q2 25
71.2%
Q1 25
68.8%
Q4 24
70.0%
Q3 24
68.8%
Q2 24
69.9%
Q1 24
66.3%
Operating Margin
ESNT
ESNT
IRTC
IRTC
Q4 25
59.1%
1.1%
Q3 25
63.9%
-4.4%
Q2 25
72.4%
-10.0%
Q1 25
65.2%
-20.5%
Q4 24
61.9%
-2.5%
Q3 24
65.6%
-34.1%
Q2 24
76.4%
-15.5%
Q1 24
71.6%
-28.9%
Net Margin
ESNT
ESNT
IRTC
IRTC
Q4 25
49.6%
2.7%
Q3 25
52.7%
-2.7%
Q2 25
61.2%
-7.6%
Q1 25
55.2%
-19.3%
Q4 24
53.3%
-0.8%
Q3 24
55.6%
-31.3%
Q2 24
65.1%
-13.6%
Q1 24
60.9%
-34.6%
EPS (diluted)
ESNT
ESNT
IRTC
IRTC
Q4 25
$1.61
$0.18
Q3 25
$1.67
$-0.16
Q2 25
$1.93
$-0.44
Q1 25
$1.69
$-0.97
Q4 24
$1.59
$-0.03
Q3 24
$1.65
$-1.48
Q2 24
$1.91
$-0.65
Q1 24
$1.70
$-1.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESNT
ESNT
IRTC
IRTC
Cash + ST InvestmentsLiquidity on hand
$583.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$5.8B
$152.7M
Total Assets
$7.4B
$1.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESNT
ESNT
IRTC
IRTC
Q4 25
$583.8M
Q3 25
$565.2M
Q2 25
$545.5M
Q1 25
$520.6M
Q4 24
$535.6M
Q3 24
$522.0M
Q2 24
$561.5M
Q1 24
$569.1M
Stockholders' Equity
ESNT
ESNT
IRTC
IRTC
Q4 25
$5.8B
$152.7M
Q3 25
$5.7B
$121.9M
Q2 25
$5.7B
$103.7M
Q1 25
$5.7B
$86.7M
Q4 24
$5.6B
$90.9M
Q3 24
$5.6B
$71.8M
Q2 24
$5.4B
$99.2M
Q1 24
$5.2B
$90.3M
Total Assets
ESNT
ESNT
IRTC
IRTC
Q4 25
$7.4B
$1.0B
Q3 25
$7.4B
$995.2M
Q2 25
$7.2B
$964.0M
Q1 25
$7.2B
$926.1M
Q4 24
$7.1B
$931.4M
Q3 24
$7.1B
$909.7M
Q2 24
$6.7B
$919.2M
Q1 24
$6.6B
$909.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESNT
ESNT
IRTC
IRTC
Operating Cash FlowLast quarter
$856.1M
$26.2M
Free Cash FlowOCF − Capex
$848.7M
$14.5M
FCF MarginFCF / Revenue
271.7%
6.9%
Capex IntensityCapex / Revenue
2.4%
5.6%
Cash ConversionOCF / Net Profit
5.52×
4.70×
TTM Free Cash FlowTrailing 4 quarters
$1.5B
$34.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESNT
ESNT
IRTC
IRTC
Q4 25
$856.1M
$26.2M
Q3 25
$215.9M
$34.9M
Q2 25
$189.5M
$27.7M
Q1 25
$221.6M
$-7.9M
Q4 24
$861.5M
$19.2M
Q3 24
$229.2M
$24.3M
Q2 24
$188.7M
$11.8M
Q1 24
$216.9M
$-52.0M
Free Cash Flow
ESNT
ESNT
IRTC
IRTC
Q4 25
$848.7M
$14.5M
Q3 25
$210.6M
$20.1M
Q2 25
$188.8M
$17.3M
Q1 25
$221.3M
$-17.3M
Q4 24
$854.8M
$12.4M
Q3 24
$228.7M
$15.5M
Q2 24
$187.6M
$3.4M
Q1 24
$212.5M
$-61.8M
FCF Margin
ESNT
ESNT
IRTC
IRTC
Q4 25
271.7%
6.9%
Q3 25
67.5%
10.4%
Q2 25
59.2%
9.3%
Q1 25
69.7%
-10.9%
Q4 24
271.3%
7.5%
Q3 24
72.2%
10.5%
Q2 24
60.0%
2.3%
Q1 24
71.2%
-46.8%
Capex Intensity
ESNT
ESNT
IRTC
IRTC
Q4 25
2.4%
5.6%
Q3 25
1.7%
7.7%
Q2 25
0.2%
5.6%
Q1 25
0.1%
5.9%
Q4 24
2.1%
4.2%
Q3 24
0.2%
6.0%
Q2 24
0.3%
5.7%
Q1 24
1.5%
7.4%
Cash Conversion
ESNT
ESNT
IRTC
IRTC
Q4 25
5.52×
4.70×
Q3 25
1.31×
Q2 25
0.97×
Q1 25
1.26×
Q4 24
5.13×
Q3 24
1.30×
Q2 24
0.93×
Q1 24
1.19×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESNT
ESNT

Mortgage Insurance Segment$192.4M62%
Other$120.0M38%

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

Related Comparisons